Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection
Joseph G. Skeate(University of Southern California), W. Martin Kast(University of Southern California), Tania B. Porras(University of Southern California), Julia R. Taylor(University of Southern California), Jae U. Jung(Cleveland Clinic), Thomas J. Kelly(University of Florida), Heike E. Brand(University of Southern California), Julie K. Jang(University of Southern California), Weiming Yuan(University of Southern California), Andrew W. Woodham(Emulate (United States))
Cited by 21
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Autophagy during viral infection — a double-edged sword
|Nature Reviews Microbiology|2018|812